PODCAST: Mark Pownall and Mark Beyer discuss North West Shelf shakeup, Westport development, broker consolidation, DUG Technology IPO, environmental approvals, #Perth, universities, and our special report on apartment developments.…
Calling for a freeze in the creation of new posts, rationalisation of manpower at workshops, shifting outsourced work to CSR, moving ceremonial functions to digital platforms, cutting down on use of stationary by 50 per cent — the railways is gearing up to adopt a slew of austerity measures proposed by its financial commissioner in view of the serious dent in its earnings this year due to the coronavirus crisis.
In a letter dated June 19, the financial commissioner of the railways told the general managers of all the zones that the traffic earnings of the national transporter dropped by 58 per cent at the end of May, as compared to the corresponding period of the previous year.
“There is a need to explore new areas of expenditure control and enhancement of earnings,” the letter said.
It stated that such measures were already announced by the then financial commissioner in 2017 and the Railway Board in 2019.
“As you are aware, the railways has been mandated by the government to meet all of its
Homegrown pharma major Cipla Ltd announced the launch of its generic version of remdesivir, which has been authorised for emergency use in treatment of Covid-19 patients by the USFDA, under its brand name Cipremi.
The USFDA had issued an Emergency Use Authorization (EUA) to Gilead Sciences Inc for emergency use of remdesivir for the treatment of Covid-19 patients.
Remdesivir is the only USFDA approved Emergency Use Authorisation (EUA) treatment for adult and paediatric patients hospitalised with suspected or laboratory confirmed Covid-19 infection.
In May, Gilead Sciences Inc extended a voluntary non-exclusive license to Cipla to manufacture and market generic version of remedisvir called Cipremi.
Cipla said it has been granted regulatory approval by the Drug Controller General of India (DCGI) for restricted emergency use in the country as part of the accelerated approval process considering the urgent and unmet medical need.
“As part of a risk management plan, Cipla will provide training on use of the drug, informed patient consent documents, conduct post marketing surveillance as well as conduct a Phase IV clinical trial on Indian patients,” the company said in a statement.
Dutch police on Sunday charged on horseback and fired water cannon to disperse protesters frustrated with the government’s coronavirus policies, arresting dozens after skirmishes broke out.
Hundreds of people gathered in the city centre, many carrying placards or holding hands, to demonstrate against measures including the 1.5 metre social distancing rule.
Acting mayor Johan Remkes had initially barred the protest but later agreed to a time-limited demonstration.
Police said the protest was peaceful until a group of football fans clashed with riot police at the nearby Central Station, throwing stones and bottles.
Officers later surrounded dozens of demonstrators who refused to leave.
“The remaining demonstrators refused to leave and have been detained under public demonstration legislation,” The Hague police said in a tweet.
“Five people have also been detained at Central Station for throwing stones.”
The Netherlands has been commended for its “intelligent lockdown” approach, which was less strict than some other European countries, with no full stay-at-home orders.
Restaurants, cinemas, cafes, museums and terraces were all authorised to open on June 1, but with social distancing rules in place and establishments limited to a maximum of 30 customers.
The Netherlands has confirmed 49,593 cases and 6,090 deaths, with one